HOOK (HOOKIPA Pharma Inc.) Forward P/E Multiple
HOOKIPA Pharma Inc. (HOOK) retains a staff of leading immunologists through stock option programs, minimizing turnover. Business success is based on grants and the results of cancer vaccine trials. The company's expected P/E multiple valuation helps identify undervalued assets, while the 0.00 value reflects the metric's balance. Infrastructure risks are mitigated by separating R&D in Austria from serial production at US-based CMO sites.
Analytical breakdowns for HOOKIPA Pharma Inc.
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
Total Debt to Equity Ratio HOOKIPA Pharma Inc.|HOOK - Long-Term Debt to Capital|Short-Term Debt to Equity HOOKIPA Pharma Inc.|HOOK - Company Aggregate Debt|Debts to Book Capitalization HOOKIPA Pharma, Inc.|HOOK - Long-Term Debt|Company Short-Term Debts HOOKIPA Pharma|Quick Liquidity hookipapharma.com
- company profitability and valuation multiples indicators:
HOOK - Company Net Income|Expected Profit HOOKIPA Pharma Inc.|HOOK - Market Cap to Earnings|Future Price to Earnings HOOKIPA Pharma Inc.|HOOK - PEG Multiple|EV/EBITDA Multiple HOOKIPA Pharma, Inc.|HOOK - Operating income before deduction of amortization|Earnings per share for the last twelve months HOOKIPA Pharma|HOOK - Earnings per one share for the last 12 months|Quarterly EPS earnings growth hookipapharma.com|HOOK - Earnings growth in current year|Expected earnings per share growth for next year HOOKIPA Pharma Inc.
Summary company analytics:HOOKIPA Pharma
The forward P/E reflects the ratio of the current share price to the projected annual net income, measuring the speed at which the market re-rates the business. In the context of HOOKIPA Pharma Inc. (HOOK) and its reliance on external Big Pharma financing, the company's forward P/E allows for an assessment of how much the market currently prices in the success of software development partnership agreements amid limited internal capital.
Competitors of HOOKIPA Pharma Inc. (HOOK)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|Future Price to Earnings Multiple ABCL (AbCellera Biologics)|Tourmaline Bio, Inc. (TRML) - Future Price to Earnings|Projected Price to Earnings Ratio precigen.com (PGEN)|Future Price to Earnings Pharming Group|Projected Price to Earnings Ratio Nektar Therapeutics Inc NKTR|Future Price to Earnings Upstream Bio Corp (UPB)|Forward P/E Multiple Zenas Corp (ZBIO)|Forward P/E Multiple IMNM (Immunome, Inc.)|Market Cap to Projected Earnings gossamerbio.com (GOSS)|KALV - Future Price to Earnings|Price to Expected Earnings Ratio SEPN|PVLA: Forward P/E Multiple|Savara Pharma (SVRA) - Forward P/E Multiple|Projected Price to Earnings RIGL|ANAB: Future Price to Earnings Multiple|Future Price to Earnings Astria Therapeutics, Inc. (ATXS)|ENGN: Price to Expected Earnings Ratio|Forward P/E Multiple RAPT (RAPT Therapeutics, Inc.)|Future Price to Earnings Multiple JBIO|Aclaris Therapeutics - Forward P/E Multiple|KYTX - Forward P/E Multiple|Tiziana Life Sciences Ltd (TLSA) - Future Price to Earnings|Cabaletta Bio Inc. - Future Price to Earnings Multiple|Future Price to Earnings Ventyx Bio|Projected Price to Earnings Theratechnologies, Inc (THTX)|Forward P/E Multiple AVTX|Forward P/E Multiple eledon.com (ELDN)|Agenus Inc. - Projected Price to Earnings|Future Price to Earnings Multiple CLYM|Zura Bio Limited - Forward P/E Multiple|Market Cap to Projected Earnings aTyr Pharmaceuticals ATYR|adagene.com (ADAG) - Future Price to Earnings|Price to Future Earnings Ratio IMA|STTK (Shattuck Labs Inc) - Forward P/E Multiple|Projected Price to Earnings Equillium Bio (EQ)|Projected Price to Earnings CNTB (Connect Biopharma)|Market Cap to Projected Earnings immunic-therapeutics.com|Forward P/E Multiple ATRA (Atara Bio)|Future Price to Earnings Multiple IFRX|XFOR - Future Price to Earnings|Projected Price to Earnings Ratio Adicet Bio|celularity.com (CELU) - Future Price to Earnings|Projected Price to Earnings Ratio INmune Bio Corporation (INMB)|Future Price to Earnings Barinthus Biotherapeutics|Forward P/E Multiple kezarlifesciences.com|Future Price to Earnings SAB Biotherapeutics, Inc. (SABS)|AKTX: Price to Expected Earnings Ratio|Forward P/E Multiple ENLV (Enlivex Therapeutics Ltd.)|Future Price to Earnings Multiple QTTB|GeoVax Labs, Inc. - Forward P/E Multiple|EDSA - Forward P/E Multiple|iBio (IBIO) - Future Price to Earnings|Carisma Therapeutics Inc. - Future Price to Earnings Multiple|Future Price to Earnings XTL Biopharmaceuticals, Ltd.|Projected Price to Earnings Bolt Bio (BOLT)|Forward P/E Multiple HCWB|Forward P/E Multiple aptevotherapeutics.com (APVO)|AIM ImmunoTech - Projected Price to Earnings|Future Price to Earnings Multiple ADTX|GRI Bio Corp - Forward P/E Multiple|Market Cap to Projected Earnings XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Future Price to Earnings|Projected Price to Earnings revbiosciences.com|Future Price to Earnings Indaptus Therapeutics, Inc.|Projected Price to Earnings Scinai Immunotherapeutics Ltd (SCNI)|Projected Price to Earnings CALI (CalciMedica, Inc.)|Forward P/E Multiple affimed.com (AFMD)|Future Price to Earnings Allakos ALLK|IGMS: Price to Future Earnings Ratio|iTeos Therapeutics, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio Ocean Biomedical Inc|TCBP: Forward P/E Multiple|Third Harmonic Bio Inc - Future Price to Earnings Multiple
